. Schematic presentation of the melanoma antigen extract preparation (acid wash extract; AWE) used as tumor-associated peptide vaccine. B16.F1 cells were washed with HBSS and incubated for 5 min in citrate buffer pH 3.0. After centrifugation to remove cell debris, the supernatant containing the detached peptides was immediately processed on a pre-conditioned (with 10 mL ethanol and 20 mL d. H2O) SepPak C18 cartridge. The peptide-bound material was eluted from the column with 5 mL 80% acetonitrile, lyophilized to dry and reconstituted in 1 mL HBSS. To recover peptides with MW < 10 kDa, the peptide mixture was filtered through a Centricon filter and the flow through material was used as peptide vaccine. Each dose being administered to mice contained peptides that were eluted from 2 × 10 7 B16.F1 cells. Figure S2 . In vivo titration studies of B16.F1 cells injected s.c. to C57BL/6 mice. Tumor growth was recorded every 2 to 3 days by measuring the major and minor axes of the masses via a digital caliper. Tumor volumes were calculated using the formula: tumor volume (cm 3 ) = major axis × minor axis 2 × 0.5. Mean volumes from 4 animals/B16.F1 dose are shown. SDs are omitted for clarity. For the
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(A) (B) Figure S3 . Assessment of cytokine and chemokine levels in mice serum. The sera used were collected: for the PBS group on day 34; for AWE, GM-CSF and scrambled groups on day 48; for proTα and proTα(100-109) groups on day 54. (A) Sera were assessed in duplicate with ELISAs specific for the cytokines IFN-γ (Th1) and IL-4 (Th2), performed according to the manufacturers' instructions. Mean concentrations ± SD from 4-5 animals are shown. Based on the levels of IFN-γ, the in vivo predominance of Th1-type immune responses seems likely. (B) The same sera were assessed with a 20-plex Luminex assay. Samples were diluted 1:2 in assay diluent; 25 μL of 1× antibody beads were added into each well of a 96-well flat bottom plate; wells were washed with 200 μL of 1× wash solution; 50 μL incubation buffer was added; 100 μL of diluted standards, blank and diluted samples were added in the relevant wells; the plate was covered and incubated on an orbital plate shaker (2 h; room temperature); wells were washed twice with 200 μL 1× wash solution; 1× biotinylated detector antibody (100 μL biotin diluent and 10 μL 10× biotinylated antibody/well) was added; the plate was incubated on an orbital shaker (1 h; room temperature); wells were washed twice with 200 μL 1× wash solution; 100 μL 1× streptavidin-RPE solution (100 μL RPE-diluent and 10 μL 10× streptavidin-RPE/well) was added; the plate was incubated on an orbital shaker (30 min; room temperature); wells were washed thrice with 200 μL 1× wash solution; 150 μL 1× wash solution was added to each well; the plate was placed on a shaker for 2 to 3 min and then analyzed into a Luminex ® 100/200™ instrument. Cytokine and chemokine concentrations were determined from the standard curve using curve fitting software. Mean values from sera of 4-5 animals were calculated and expressed in a heatmap (MATLAB software, by MathWorks ® ) as fold-increase compared to the levels detected in the PBS-treated group defined as 0. The colors of the heatmap were mapped linearly as in the color key shown (low concentration in brown; high concentration in green).The levels of proinflammatory cytokines (IL-1α, IL-1β, TNF-α, IL-6, IL-12) and chemokines (MCP-1, MIP-1α) as well as Th1-type cytokines (IL-2, IFN-γ) were found increased in the serum of proTα/AWE-and proTα(100-109)/AWE-treated animals.
